Site icon New

HEMOSTASIS

HEMOSTASIS


HEMOSTASIS
  • Hemostasis – Stoppage of bleeding.
  • Occurs in 3 major steps –

– Vasoconstriction of damaged vessels.

– Hemostatic plug formation.

– Clot retraction & dissolution.

1. VASOCONSTRICTION:

  • Initial injury results in brief period arteriolar vasoconstriction.

– Ie., Minimizing vessel diameter & slowing bleeding.

  • Occurs due to reflex neurogenic mechanism.

– Augmented by “Endothelin” – Potent endothelium-derived vasoconstrictor.

  • Effect is transient.
  • Without activation of platelet & coagulation system, bleeding resumes.

2. FORMATION OF HEMOSTATIC PLUG:

  • Occurs in 2 stages – 

– Primary hemostasis – Formation of platelet plug.

– Secondary hemostasis – Consolidation of platelet plug.

2a. PRIMARY HEMOSTASIS:

  • Step for platelet plug formation.

Endothelial injury exposes highly thrombogenic subendothelial extracellular matrix.

Allows platelet adherence/ binding to ECM collagen.

Binding activated cell release secretory granules & its products.

Recruits additional platelets forming “Primary hemostatic plug” (Platelet Plug).

2B. SECONDARY HEMOSTASIS:

  • Step for consolidation of platelet plug.

Coagulation system is activated & thrombin is generated.

Thrombin converts fibrinogen to fibrin.

Ultimately forms an irreversibly fused mass of platelets, thrombin, RBCs & fibrinogen.

Definitive secondary hemostatic plug.

3. CLOT RETRACTION & DISSOLUTION:

Clot retraction – 

  • Shrinking of clot pulls wound edges together, making wound healing easier.
  • Occurs due to contraction of platelets

Dissolution of clot – 

  • Fibrinolysis.
  • Necessary for normal blood flow restoration to healed tissue.
  • Fibrinolysis is produced by plasmin.
  • Activation product of fibrinolytic system.

ROLE OF ENDOTHELIUM IN HEMOSTASIS:

  • Endothelial cells, 

– Promotes blood fluidity by antithrombotic properties.

– Conversely, also exhibits procoagulant activity post-injury to arrest bleeding.

PROPERTIES OF ENDOTHELIUM: 

  • Includes Anti- & Pro-Thrombotic properties.

1. ANTI-THROMBOTIC PROPERTIES:

Includes – 

  • Antiplatelet effects.
  • Anticoagulant effects.
  • Fibrinolytic effect.
  • Endothelial cells maintain blood fluidity.

Vascular endothelium – 

  • Smooth, coated with a layer of glycocalyx (mucopolysaccharide).
  • Thus, preventing intrinsic system activation.
  • Repelling clotting factors & platelets.
  • Hence, preventing clotting of blood within vessels.

1a. Anti-platelet effects:

  • Intact endothelium prevents platelet contact to highly thrombogenic subendothelial ECM.

– Especially collagen.

  • Endothelium secretes PGI2 & NO.

– Both are inhibitors of platelets aggregation.

  • Produces ADP’ase

– Degrades ADP.

– Potent platelet stimulator.

1b. Anti-coagulant effect:

  • Endothelium has membrane-bound heparin-like molecule.

– Binds with antithrombin III.

  • Inactivates factor II (thrombin), IX, X, XI, XII.

– Produces thrombomodulin.

– In turn, binds to thrombin → Converting procoagulant to anti-coagulant, capable of activating protein C.

  • Protein ‘C’ along with protein ‘S’ acts as co-factor.

– Results in proteolytic cleavage of factor V & VIII.

  • All endothelial cells produce thrombomodulin except cerebral circulation.

– Produces “Tissue Factor Pathway Inhibitor”.

– Inactivates tissue factors VII & X.

1c. Fibrinolytic effect:

  • Endothelial cells synthesize tissue-type plasminogen activator (t-PA).

– Converts plasminogen to plasmin.

– In turn, dissolving clot by breaking fibrin.

2. PRO-THROMBOTIC  PROPERTIES:

  • By following effects,

2a. Platelet effects:

  • Endothelial cell injury exposes highly thrombogenic subendothelial ECM.

– Allowing platelet adherence to ECM collagen.

  • Due to ↑ed Von-Willebrand factor production by endothelium.

– An essential cofactor for platelet binding to collagen.

2b. Pro-Coagulant effects:

  • Endothelial cells synthesize tissue factor.

– Activates extrinsic coagulation pathway.

2c. Anti-Fibrinolytic effect:

  • Endothelial cells secretes Plasminogen Activator Inhibitors (PAI’s).

– Inhibits plasminogen activator action.

– Plasmin is not produced from plasminogen → Hence, no fibrinolysis.

ROLE OF PLATELET IN HEMOSTASIS:

  • Platelets play central role in normal hemostasis.

– After endothelial injury, 

  • Platelets contacts subendothelial ECM (especially collagen).

Results in platelets reactions –

  • Adhesion.
  • Secretion.
  • Platelet aggregation.

1. Adhesion:

  • Platelets adhesion to extracellular matrix, mediated largely via interaction with Von-Willebrand factor (VWF).
  • Acts like bridge between platelet surface receptor GP1b & exposed collagen.

2. Secretion:

  • Secretes Thromboxane A2 & Serotonin.
  • Results in vasoconstriction.

3. Platelet aggregation:

  • Primary platelet plug formation stabilized by,

– Coagulation system activation.

– Thrombin formation.

– Thrombin stabilizes primary platelet plug into secondary platelet plug.

  • During dissolution stage, 

– Platelet contraction occurs due to contractile proteins like thrombosthenin, actin & myosin.

– Platelet contraction cause clot retraction.

– Results in easier wound healing.

Factors promoting platelet aggregation:

  • TXA2.
  • Serotonin.
  • Immune complex.
  • Thrombin.
  • vWF.
  • Fibrinogen.
  • ADP.
  • Epinephrine.
  • Collagen.
  • Thrombospondin.
Factors inhibiting platelet aggregation:
  • PGI2.
  • Nitric oxide.
  • Endothelin.
  • Bradykinin.

Exam Important

HEMOSTASIS
  • Thrombin converts fibrinogen to fibrin.
  • Clot retraction occurs due to contraction of platelets.
  • Vascular endothelium is smooth, coated with a layer of glycocalyx (mucopolysaccharide).

– Prevents intrinsic system activation.

– Repelling clotting factors & platelets.

– Hence, preventing blood clotting within vessels.

Anti-coagulant property of endothelium:

  • All endothelial cells produce thrombomodulin except cerebral circulation.

– Results in proteolytic cleavage of factor V & VIII.

  • After endothelial injuryplatelets contacts subendothelial ECM (especially collagen).
  • Platelet secretes Thromboxane A2 & Serotonin” → Results in vasoconstriction.
  • Platelet contraction cause clot retraction.

– Occurs due to contractile proteins like thrombosthenin, actin & myosin.

Factors promoting platelet aggregation:

  • TXA2.
  • Serotonin.
  • Immune complex.
  • Thrombin.
Factors inhibiting platelet aggregation:
  • PGI2.
  • Bradykinin
Don’t Forget to Solve all the previous Year Question asked on HEMOSTASIS
Click Here to Start Quiz

Exit mobile version